Cooperative Study Group for Autoimmune Disease Prevention

The summary for the Cooperative Study Group for Autoimmune Disease Prevention Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Cooperative Study Group for Autoimmune Disease Prevention
	CFDA Number:	93.11393.847
	CFDA Description:	Biological Response to Environmental Health Hazards 93.847 Diabetes, Endocrinology and Metabolism Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Income Security and Social Services Health Environment
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-AI-05-026
	Document Type:	Grants Notice
	Funding Instrument Type:	Cooperative Agreement
	Posted Date:	May 12, 2005
	Creation Date:	May 12, 2005
	Original Closing Date for Applications:	Oct 12, 2005
	Current Closing Date for Applications:	Information not provided
	Archive Date:	Nov 11, 2005
	Expected Number of Awards:	4
	Estimated Total Program Funding:	$4,500,000
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	93.855 -- Allergy, Immunology and Transplantation Research

Applicants Eligible for this Grant: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Small businesses Public and State controlled institutions of higher education Private institutions of higher education State governments County governments City or township governments Special district governments Independent school districts Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Eligible agencies of the Federal Government are eligible to apply. Foreign institutions are eligible to apply. Foreign institutions are not eligible to apply as the primary institution on a multi-project (U19) application, but may enter into a consortium or subcontract with a domestic institution as the primary applicant. Foreign institutions are eligible to submit single-project (U01) applications.
Grant Description: Single institutions or consortia of institutions are invited to participate in a cooperative research group focusing on prevention of human autoimmune diseases, with an emphasis on type 1 diabetes. In FY 2006, the co-sponsoring NIH Institutes and the Juvenile Diabetes Research Foundation International (JDRFI) anticipate awarding a total of $4.5 million to fund four to six awards, using the single-project (U01) and multi-project (U19) cooperative agreement award mechanisms. Additional discretionary funds of approximately $2.5 million will be allocated to the Study Group to fund innovative collaborative, discovery-based, and/or pilot and feasibility projects consistent with the overall goal of autoimmune disease prevention. Eligible institutions include for-profit or non-profit organizations; public or private institutions, such as universities, colleges, hospitals, and laboratories; units of State and local governments; or eligible agencies of the Feder! al government. Foreign institutions are not eligible to apply as the primary applicant institution in a multi-project application, but may submit a single-project application or enter into a consortium with a domestic institution as the primary applicant. This RFA will not support clinical trials or studies of global immunosuppressive therapies, and proposals for clinical trials may not be submitted in the initial application. Any individual with the skills, knowledge, and resources necessary to carry out the proposed research is invited to work with his or her institution to develop an application as the Principal Investigator. A Principal Investigator may submit only one application. However, participation of a Principal Investigator as a project leader in multi-project applications (U19 mechanism) is allowed if there is no scientific overlap with the application submitted by the Principal Investigator. Applications must be prepared using the most current PHS 398 research! grant application instructions and forms, available at http://grants. nih.gov/grants/funding/phs398/phs398.html. For further assistance contact GrantsInfo, telephone (301) 435-0714, email: GrantsInfo@nih.gov. Telecommunications for the hearing impaired is available at: TTY 301-451-0088.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-05-026.html http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-05-026.html
Grant Announcement Contact: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster